To include your compound in the COVID-19 Resource Center, submit it here.

2Q milestones

2Q milestones

Ablynx N.V. (Euronext:ABLX)ALX-0171Respiratory syncytial virus (RSV) infectionPh I/IIa data2Q16
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)Nuplazid pimavanserinParkinson's disease psychosis (PDP)PDUFA date5/1/16
Acucela Inc. (Tokyo:4589) / Otsuka Pharmaceutical Co. Ltd.EmixustatGeographic atrophy associated with dry age-related macular degeneration (AMD)Ph IIb/III data2Q16
Advaxis Inc. (NASDAQ:ADXS)Axalimogene filolisbac (ADXS11-001)HPV-associated head and neck cancerPh II dataApril
Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) BrigatinibAdvanced or metastatic non-small cell lung cancer (NSCLC)Ph II data2Q16
ArQule Inc. (NASDAQ:ARQL) / Daiichi Sankyo Co. Ltd. (Tokyo:4568)

Read the full 662 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers